Stifel raises Rapport Therapeutics stock price target to $56 on positive trial data

2 months ago 9
Read Entire Article
  1. Homepage
  2. Finance
  3. Stifel raises Rapport Therapeutics stock price target to $56 on positive trial data

Related

Pets, anime and toys are part of China’s latest effort to boost consumption

Pets, anime and toys are part of China’s latest effort to bo...

30 minutes ago 0
Half-Year Report IOMART GROUP PLC For: 26 November

Half-Year Report IOMART GROUP PLC For: 26 November

30 minutes ago 1
Half-Year Report HELICAL PLC For: 26 November

Half-Year Report HELICAL PLC For: 26 November

30 minutes ago 0

Trending

1. play
2. cathay pacific
3. nvidia news
4. rockstar
5. philip seymour hoffman
6. bts
7. jd
8. hayden christensen
9. iphone 14
10. lebron james

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 610
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 481
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 335
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 300
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 294
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved